Beijing Konruns Pharmaceutical News

Announcement of Resolutions of the Second Meeting of Holders of Kangchen Pharmaceutical\'s Phase I Employee Stock Ownership Plan

Dec 7 00:00

Legal Opinion of Beijing Guofeng Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Beijing Kangchen Pharmaceutical Co., Ltd.

Oct 30 00:00

Announcement of Resolutions of Kangchen Pharmaceutical\'s 2024 Second Extraordinary General Meeting of Shareholders

Oct 30 00:00

Kangchen Pharmaceutical\'s announcement on reducing registered capital to notify creditors

Oct 30 00:00

Kangchen Pharmaceutical 2024 Second Extraordinary General Meeting of Shareholders Meeting Materials

Oct 23 00:00

Kangchen Pharmaceutical: Kangchen Pharmaceutical\'s announcement on changing the company\'s registered capital and amending the “Articles of Association”

Sep 30 00:00

Kangchen Pharmaceutical: Notice on Cancelling the Company\'s Repurchase of Shares in Special Securities Accounts

Sep 30 00:00

Kangchen Pharmaceutical: Kangchen Pharmaceutical\'s Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024

Sep 30 00:00

Kangchen Pharmaceutical: Announcement on the repurchase and cancellation of some restricted stocks that have been granted incentives but sales restrictions have not yet been lifted, and the adjustment of repurchase prices

Sep 30 00:00

Kangchen Pharmaceutical\'s Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024

Sep 30 00:00

Articles of Association of Beijing Kangchen Pharmaceutical Co., Ltd. (Revised in September 2024)

Sep 30 00:00

Kangchen Pharmaceutical\'s announcement on changing the company\'s registered capital and revising the “Articles of Association”

Sep 30 00:00

Kangchen Pharmaceutical\'s announcement on the appointment of Chief Financial Officer

Aug 28 00:00

Beijing Kangchen Pharmaceutical Co., Ltd. Accountant Service Selection and Employment System

Aug 28 00:00

Announcement of Resignation of Senior Management Personnel from Beijing Konruns Pharmaceutical

Aug 1 00:00

Announcement from Beijing Konruns Pharmaceutical on traditional Chinese medicine innovative drug ZY5301 clinical research results being featured in the sub-journal of JAMA.

Jul 30 00:00

Announcement on the Change of Continuous Supervision and Sponsorship Representative of Beijing Konruns Pharmaceutical

Jul 27 00:00

Announcement on the signing of house rental contract and related trade of Beijing Konruns Pharmaceutical

Jul 4 00:00

Kangchen Pharmaceutical's announcement on being certified as the 8th batch of national manufacturing individual champion enterprises

May 21 00:00

Announcement of Resolutions of Kangchen Pharmaceutical's 2023 Annual General Meeting of Shareholders

May 17 00:00